To determine the expression patterns of AURKA, immunohistochemistry staining of AURKA on a tissue microarray of 94 well-annotated NSCLC lung cancer tumor samples from patients with stage I-III lung cancer who underwent resection between 2010 and 2012 was pursued (Figure 1). Here, AURKA is linked to non-small cell lung carcinoma.